Compare POWW & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POWW | MXCT |
|---|---|---|
| Founded | 1990 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.6M | 186.7M |
| IPO Year | N/A | 2021 |
| Metric | POWW | MXCT |
|---|---|---|
| Price | $2.03 | $1.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.38 | ★ $7.50 |
| AVG Volume (30 Days) | 358.4K | ★ 1.5M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $46,632,638.00 | $34,419,000.00 |
| Revenue This Year | $9.85 | N/A |
| Revenue Next Year | $1.15 | $10.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1343.57 | N/A |
| 52 Week Low | $0.95 | $1.26 |
| 52 Week High | $2.14 | $5.20 |
| Indicator | POWW | MXCT |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 50.33 |
| Support Level | $1.79 | $1.50 |
| Resistance Level | $1.96 | $1.65 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 79.17 | 47.37 |
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.